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In This IssueiNOS Inhibitors Clear the Smoke
PAGE 293
Using mice chronically exposed to tobacco smoke, Seimetz et al. show
that inducible nitric oxide synthase (iNOS) plays a role in the development
of two lung diseases associated with smoking, emphysema and pulmonary
hypertension. Knockout of iNOS protects the mice against these chronic
diseases, whereas treatment of tobacco-exposed wild-type mice with an
iNOS inhibitor prevents and even reverses established lung disease.Breaking Bcr-Abl Resistance in Leukemia
PAGE 306
The oncogenic fusion protein Bcr-Abl is a constitutively active tyrosine
kinase that initiates chronic myeloid leukemia. Although specific tyrosinekinase inhibitors exist, resistance mutants eventually arise, reducing the clinical usefulness of such drugs. Grebien
et al. now identify an intramolecular interface within the Bcr-Abl protein that is essential for oncogenic activity. Disrup-
tion of the interface not only prevents leukemia formation inmice, but also enhances the effectiveness of tyrosine kinase
inhibitors against resistant Bcr-Abl mutants.Spooky Intron Action
PAGE 320
Most yeast introns are found in duplicated ribosomal protein (RP) genes. Parenteau et al. examine the functional contri-
bution of these introns and find that deleting an intron from one paralog modifies the expression of both RP paralogs.
The intron-dependent change in RNA expression alters cell fitness and response to stress, showing that introns can
control optimal expression and function of RP genes.STING Steers STAT Signaling
PAGE 447
JAK/STAT signaling mediates adaptive immunity by controlling transcription in response to cytokines. Chen et al. now
show that STAT6 is also activated directly by virus-sensing platforms at the endoplasmic reticulum, independently of
JAK. Viral nucleic acids trigger STING (also known as ERIS/MITA) to recruit
STAT6, facilitating its phosphorylation by TBK1 and promoting the expres-
sion of distinct target genes required for antiviral innate immunity.Enhancers Stitch It Up
PAGE 332
Changes in nuclear positioning and chromatin compaction at the immuno-
globulin heavy-chain (IgH) locus are required prior to recombination. Guo
et al. demonstrate that the conformation of this huge locus is generated
in two enhancer-mediated steps. In the first step, the Em enhancer reconfig-
ures the locus into several multilooped domains. Then, Em brings these
domains together to generate a compacted structure in which the ends
are in spatial proximity.Cell 147, October 14, 2011 ª2011 Elsevier Inc. 249
RIG-I Wriggles ‘Round Viral RNA
PAGE 409 and PAGE 423
RIG-I recognizes viral dsRNAwithin host cells and initiatesan innate immune
response. Two papers in this issue provide detailed structural and mecha-
nistic insights into this recognition event. Luo et al. report the structure of
RIG-I, lacking the N-terminal CARD domains, in complex with dsRNA,
showing how the protein wraps around the RNA and how the organization
within the complex supports RIG-I multimerization. In a series of structures
including full-length RIG-I, Kowalinski et al. provide insight into the confor-
mational changes that occur as RIG-I binds viral RNA and ATP to trigger
signaling through the CARD domains. Together, these studies illuminate
key steps leading to stimulation of an interferon response to infection.ceRNAs Soak Up Oncogenic MicroRNAs
PAGE 344, PAGE 370, and PAGE 382Individual genes often contain binding sites for multiple microRNAs, and conversely, individual microRNAs often target
multiple RNA transcripts. Now, three studies identify a large regulatory network of RNA transcripts that controls the
tumor suppressor PTEN by sequestering its microRNAs. Tay et al. and Sumazin et al. demonstrate that 20 of these
‘‘competitive endogenous RNAs’’ (ceRNAs) exhibit tumor suppressor activity in multiple types of cancers, and Karreth
et al. discover a PTEN ceRNA that, when lost, cooperates with oncogenic BRAF to promote melanoma in a mouse
model. Independently, Semuzin et al. also develop a computational tool that uncovers7,000 putative ceRNAs, medi-
ating hundreds of thousands of pair-wise gene interactions in glioblastoma.ceRNA LINC to Muscular Dystrophy
PAGE 358
Cesana et al. discover a long noncoding RNA, linc-MD1, that governs muscle cell differentiation by competitively
binding to microRNAs that target muscle-specific transcription factors. Linc-MD1 acts as a decoy, or ‘‘competitive
endogenous RNA’’ (ceRNA), modulating the availability of these microRNAs. Interestingly, linc-MD1 also functions
as the pri-miRNA for miR-133b, and linc-MD1 levels are strongly reduced in Duchenne muscle cells.Pain Relief without the Itch
PAGE 447
Itch is a common side effect of opioid-mediated pain relief. Liu et al. now reveal that sensations of itch or pain can be
molecularly uncoupled. They provide evidence that opioid-induced itch is mediated only by neurons expressing het-
eromers of a specific isoform of the m-opioid receptor (MOR) with the gastrin-releasing peptide receptor. A distinct,
differentially expressed MOR isoform mediates analgesia. These findings provide a therapeutic target for separating
analgesia from the side effects of itch.Networks Built by Node Breakdown
PAGE 459
Emanuele et al. use two complementary approaches to identify nearly 500
Cullin-RINGubiquitin ligasesubstrates. Thiscollection isenriched forproteins
at highly connected nodes within interaction networks, indicating that
proteolysis substrates are positioned to maximally impact information flow.RF-ereeing Protein Fidelity
PAGE 396
Zaher et al. show that the E. coli translation release factor RF3, previously
thought to play a role in the recycling of other release factors, plays an
essential proofreading role in ensuring translational fidelity in vivo. The
authors show that RF3 promotes premature termination when peptides
contain errors. Protein yields increase in the absence of RF3 but at the
expense of fidelity.Cell 147, October 14, 2011 ª2011 Elsevier Inc. 251
